Phibro Animal Health Corporation updated earnings guidance for the year 2024. For the fiscal year 2024, the company expects net sales of $980 million to $1.020 billion. The company have updated fiscal year 2024 guidance for the following measures: Net income of $7 million to $12 million and Diluted EPS of $0.17 to $0.30.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.63 USD | -0.96% | -4.96% | +52.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.25% | 714M | |
-14.09% | 77.37B | |
+18.66% | 8.74B | |
+23.75% | 3.67B | |
-1.53% | 3.25B | |
+16.55% | 1.73B | |
-16.99% | 1.38B | |
+0.98% | 1.31B | |
-26.05% | 1.24B | |
-17.86% | 1.07B |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Updates Earnings Guidance for the Year 2024